[From Observation to Understanding: C3 Glomerulopathy and Immune-Complex-Associated Membranoproliferative Glomerulonephritis].

In recent years, the field of glomerulonephritis has become more accessible not only to physicians who need to understand and recognize these conditions, but also to patients who now have new treatment options available to them. For glomerulonephritis with a membranoproliferative phenotype, a better understanding of the pathophysiology has led to a new classification, enabling more targeted diagnosis; in addition, two new active ingredients have been approved for specific treatment.